このページは機械翻訳されています。他のページは英語で表示される場合があります。View in English
TGF-βとRASは,転移を誘導するプライム強化剤を共同で解明する.
Jun Ho Lee1, Francisco J Sánchez-Rivera2, Lan He1
1Cancer Biology and Genetics Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Cell
|September 7, 2024
関連する実験動画
06:54
Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
12.9K
09:18Spheroid Assay to Measure TGF-β-induced Invasion
Published on: November 16, 2011
21.8K
07:49Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling
Published on: August 3, 2018
11.3K
PubMed で要約を見る
まとめ
変換成長因子β (TGF-β) とRASシグナル伝達は,上皮からメゼンキマへの移行 (EMT) と細胞外マトリックス (ECM) の改造を調整することによって,肺腺がんの転移を誘導する. この研究は,この調整された転移プログラムを可能にする重要な染色体変異を特定します.
科学分野:
- 分子生物学
- 癌 研究
- エピジェネティクス
背景:
- 細胞外マトリックス (ECM) の改造は,がんの侵入と転移に不可欠です.
- 変換成長因子β (TGF-β) とRASシグナル伝達経路は,これらのプロセスを誘導することが知られているが,それらの調整された調節は完全に理解されていない.
研究 の 目的:
- 肺腺がん転移におけるEMTとECMの再構成をTGF-βとRAS信号が共同で調節する分子メカニズムを解明する.
- TGF-βとRASのシグナル入力に遺伝子発現を結びつけるクロマチンの決定因子を特定する.
主な方法:
- この研究では,RAS反応性要素結合タンパク質1 (REB1),SMADタンパク質,およびクロマチンの改変が,繊維性およびEMT遺伝子の調節における役割を調査しています.
- クロマチンの免疫降水と遺伝子発現の分析を用いて,規制要素とその関連因子を特定した.
主要な成果:
- RREB1は,ヒストンH2A.Z核細胞の特定のヒストンマーク (H4K16acK20ac) とともに,線維遺伝子の増強剤 (IL11,PDGFB,HAS2) とEMT因子SNAI1に局所する.
- これらのプライム強化剤は,TGF-βに対する反応としてSMAD4-INO80複合体によって活性化され,協調した転写プログラムが示されます.
- この調節メカニズムは,他のTGF-β応答から繊維性EMTプログラムを分離します.
結論:
- RREB1と特定のクロマチンの状態によるTGF-βとRAS信号の協調作用は,肺腺癌の転移を誘導する.
- これらの規制ネットワークを理解すると 治療的に標的となる可能性のある 転移性プログラムの脆弱性が明らかになります
関連する概念動画
01:16TGF - β Signaling Pathway
7.3K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.3K
01:07MAPK Signaling Cascades
5.3K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.3K
02:38The Ras Gene
6.2K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.2K
01:24Small GTPases - Ras and Rho
3.9K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
3.9K
02:30Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
02:38Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K